Group cognitive behavioural therapy for insomnia in adults with depression

Insomnia is common among adults living with depression, and the relationship often runs in both directions. Difficulty falling asleep, waking during the night or rising too early can intensify low mood, irritability, poor concentration and fatigue. In turn, depression may disrupt sleep timing, increase rumination and reduce daytime activity. Treating sleep symptoms is therefore an important part of whole-person mental health care.

Group cognitive behavioural therapy for insomnia, usually called CBT-I, is a structured psychological treatment that targets the habits, thoughts and behaviours maintaining sleeplessness. For Australian health services, its group format may offer a practical way to extend access while supporting consistent, evidence-informed care across metropolitan, regional and remote communities.

What the treatment involves

CBT-I usually combines sleep education with stimulus control, sleep restriction or sleep compression, cognitive restructuring and strategies for managing arousal. Participants learn to associate bed with sleep rather than worry, maintain a regular wake time and adjust time in bed to build stronger sleep pressure. Relaxation and problem-solving techniques can help people respond differently to night-time alertness.

The group setting adds a social dimension to these methods. Adults may discover that others also lie awake anticipating a poor day, check the clock repeatedly or spend long periods in bed trying to force sleep. Shared experience can reduce shame and isolation, while a clinician can correct unhelpful beliefs and tailor advice to each person’s circumstances.

Treatment is generally delivered over several sessions with sleep diaries and between-session practice. The approach is active rather than passive: progress depends on applying agreed changes at home, even when the first week feels tiring. Clear preparation is important so participants understand why an initially shorter sleep window may form part of the programme.

What the evidence suggests

Research in adults with depression indicates that CBT-I can produce meaningful improvements in insomnia severity, sleep efficiency and night-time wakefulness. Improvements in depressive symptoms are also commonly reported, although the size of the mood benefit varies between studies. Better sleep may support emotional regulation, energy and engagement with other depression treatments.

The strongest interpretation is that CBT-I is an effective treatment for co-occurring insomnia and depression, rather than a universal substitute for antidepressant medication or depression-focused psychotherapy. Some people experience a reduction in depressive symptoms after sleep improves; others still need targeted care for persistent low mood, trauma, anxiety or suicidal thinking.

Group delivery can achieve outcomes similar to individual CBT-I when the programme is well structured and facilitated by trained practitioners. It may be particularly valuable where psychology appointments are limited. Digital or telehealth support can extend reach from Brisbane to places such as Toowoomba, Cairns and Mount Isa, although reliable internet access, privacy and digital confidence need to be considered.

Who may benefit and who needs extra care

Adults with stable depression and a clear pattern of chronic insomnia are often suitable for a group programme after an initial assessment. Clinicians should review sleep timing, medicines, alcohol and other substances, physical health, work patterns and symptoms such as snoring or restless legs. Obstructive sleep apnoea, circadian rhythm disorders and untreated pain may require parallel or alternative assessment.

Sleep restriction needs careful clinical judgement for people with bipolar disorder, a history of mania, severe daytime sleepiness, epilepsy or safety-critical work. Active suicidal intent, psychosis or significant cognitive impairment may make a general group inappropriate until urgent and individualised support is in place. Screening should also identify participants who need culturally safe care, an interpreter or an approach adapted to disability and neurodivergence.

The programme should sit within a stepped-care pathway. A GP, psychiatrist, psychologist, nurse or accredited mental health professional may coordinate care, with referral to a sleep physician when symptoms suggest a sleep disorder. In Queensland, clinicians can also consider how the model fits with local Hospital and Health Service pathways and available Medicare-supported mental health appointments.

Making group care work in Australia

Australian services need to design around real lives. Shift workers, parents of young children and people travelling long distances for appointments may struggle with fixed evening sessions. Hybrid delivery, recorded education and flexible scheduling can improve access, while sleep diaries and clinical reviews still need secure handling. For First Nations communities, partnership with local Aboriginal and Torres Strait Islander health services is essential rather than treating cultural adaptation as an afterthought.

Cost and workforce capacity also shape effectiveness. Group sessions can reduce clinician time per participant, but services need funding for assessment, follow-up, supervision, administration and outcome measurement. In private practice, participants may use Medicare pathways where eligible, while public services may integrate CBT-I into depression, pain or older-person mental health programmes. Clear communication about fees and referral routes supports informed choice.

Implementation can benefit from collaboration between universities, research institutes and health services. The Brisbane Diamantina network provides a useful example of how research translation partnerships can connect evidence with clinical practice, education and service improvement. Similar collaboration can help Australian teams adapt a proven protocol without losing its core therapeutic components.

Measuring outcomes and improving translation

Effectiveness should be measured beyond whether participants attend the final session. Useful outcomes include the Insomnia Severity Index, sleep diary measures, depressive symptom scores, daytime functioning, medication changes and participant-reported quality of life. Follow-up at several weeks and months can show whether gains continue after the structured sessions end.

Services should also track reach and equity: who is referred, who starts, who completes treatment and who benefits. Results may differ according to housing stability, caring responsibilities, rural location, language, digital access and co-existing illness. Publishing these findings can guide future implementation and reduce the risk of assuming that a trial result will automatically transfer to every Australian setting.

A practical translation readiness guide can help teams examine evidence quality, local capability, governance, risks and the resources required for scale-up. Service leaders can then pilot group CBT-I, use routine outcome data, gather participant feedback and refine the model before wider adoption. Training resources and examples of clinical innovation also illustrate why implementation requires workforce development, supervision and evaluation alongside a promising intervention.

Group CBT-I offers a credible, scalable option for adults experiencing insomnia with depression. Health professionals can begin by screening sleep problems routinely, establishing referral pathways and selecting a trained facilitator. Organisations seeking broader mental health collaboration may also review NHS SMPA information when considering partnership, education or service development models. Embed sleep assessment in depression care, offer evidence-based group treatment where appropriate, and measure outcomes so that better rest becomes a practical part of better mental health.